T. Rowe Price Associates
NRC icon

T. Rowe Price Associates’s NRC Health Common Stock NRC Stock Holding History

T. Rowe Price Associates’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Buy
+9,708
New +$180K ﹤0.01% 2992
2025
Q4 		– Sell
-16,066
Closed -$206K – 3121
2025
Q3 		$206K Hold
16,066
– – ﹤0.01% 2783
2025
Q2 		$270K Buy
16,066
+951
+6% +$12.8K ﹤0.01% 2574
2025
Q1 		$194K Buy
15,115
+865
+6% +$13.9K ﹤0.01% 2656
2024
Q4 		$252K Buy
14,250
+752
+6% +$14.3K ﹤0.01% 2588
2024
Q3 		$309K Buy
13,498
+144
+1% +$3.25K ﹤0.01% 2464
2024
Q2 		$307K Buy
13,354
+668
+5% +$20.6K ﹤0.01% 2402
2024
Q1 		$503K Buy
12,686
+4,637
+58% +$183K ﹤0.01% 2208
2023
Q4 		$319K Buy
8,049
+235
+3% +$9.84K ﹤0.01% 2354
2023
Q3 		$347K Buy
7,814
+447
+6% +$19.5K ﹤0.01% 2281
2023
Q2 		$321K Buy
7,367
+165
+2% +$7.25K ﹤0.01% 2330
2023
Q1 		$314K Sell
7,202
-2,454
-25% -$108K ﹤0.01% 2324
2022
Q4 		$360K Buy
9,656
+231
+2% +$8.94K ﹤0.01% 2300
2022
Q3 		$376K Buy
9,425
+847
+10% +$31.4K ﹤0.01% 2272
2022
Q2 		$328K Buy
8,578
+1,571
+22% +$56.8K ﹤0.01% 2407
2022
Q1 		$278K Buy
7,007
+282
+4% +$11K ﹤0.01% 2580
2021
Q4 		$279K Sell
6,725
-240
-3% -$10.4K ﹤0.01% 2617
2021
Q3 		$294K Hold
6,965
– – ﹤0.01% 2588
2021
Q2 		$320K Buy
6,965
+303
+5% +$14.4K ﹤0.01% 2575
2021
Q1 		$312K Buy
+6,662
New +$324K ﹤0.01% 2555

Other funds holding NRC

Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates's NRC Position: Q2 2026 in Review

T. Rowe Price Associates opened a new position in NRC Health Common Stock (NRC) in Q2 2026: 9,708 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #2992 among its holdings. This is a return to the name: T. Rowe Price Associates previously reported a position in NRC as recently as Q3 2025.

T. Rowe Price Associates first reported a position in NRC in Q1 2021 and has held it in 20 quarters since. The position peaked at $503K in Q1 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

  • T. Rowe Price Associates held 9,708 shares of NRC Health Common Stock worth $210K as of Q2 2026.
  • NRC Health Common Stock was a new T. Rowe Price Associates position in Q2 2026.
  • NRC Health Common Stock made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2992 holding.
  • T. Rowe Price Associates first reported a position in NRC Health Common Stock in Q1 2021 and has held it in 20 quarters since.
  • T. Rowe Price Associates's NRC Health Common Stock position peaked at $503K in Q1 2024.
  • 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.